Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial
- Blinman, Prunella, Mileshkin, Linda, O'Connell, Rachel, Creutzberg, Carien L., Stockler, Martin R., Khaw, Pearly, Goss, Geraldine, Johnson, Carol, Capp, Anne, Brooks, Susan, Wain, Gerard, Kolodziej, Ilka, Veillard, Anne-Sophie
- Capp, Anne, Inostroza-Ponta, Mario, Atkinson, Chris, North, John, Poulsen, Michael, Spry, Nigel A., Tai, Keen-Hun, Wynne, Chris, Duchesne, Gillian, Steigler, Allison, Denham, James W., Bill, Dana, Moscato, Pablo, Lai, Chi, Christie, David, Lamb, David, Turner, Sandra, Joseph, David, Matthews, John
Optimal single 3T MR imaging sequence for HDR brachytherapy of cervical cancer
A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma
- Jones, Michael, Hruby, George, Holder, Carl, Oldmeadow, Christopher, Martin, Jarad, Coolens, Catherine, Driscoll, Brandon, Stanwell, Peter, Kumar, Mahesh, Capp, Anne, Sridharan, Swetha, Arm, Jameen, Gallagher, Sarah
- Lambert, Jonathon, Greer, Peter B., Kumar, Mahesh, Dowling, Jason, Hauville, Sarah, Hughes, Cynthia, Fisher, Kristen, Lau, Peter, Denham, James W., Salvado, Olivier, Menk, Fred, Patterson, Jackie, Parker, Joel, Dahl, Kara, Gupta, Sanjiv, Capp, Anne, Wratten, Chris, Tang, Colin
Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?
Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity
A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes
Are you sure you would like to clear your session, including search history and login status?